Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
about
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancerThe innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsT-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalA phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer.Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer.Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement.Single institutional experience of the treatment of angiosarcoma of the face and scalp.Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinicClinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer.Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer.A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.
P2860
Q24684241-9AB868ED-7F2F-475D-BCC0-AB6C8437B94FQ33660069-50664D1E-419C-404D-AD3C-BAD70007AE95Q34483473-11A15F07-728A-4C07-ABD0-3F3BE48CC361Q35212682-014FC65D-B5F9-419E-A0D3-ABA24CC9BE1CQ35996196-649ED9F1-C5F9-4A58-9750-F10F47826387Q36645451-1FA71B40-58D6-44FF-B07A-64A7F7EA7283Q36671690-3AE20F72-845B-488D-9FDD-AFC8E51700A4Q37193049-86A84EF0-5517-4614-935C-5B7B07B24631Q37233716-84A9F861-A9A2-425B-AF84-739D59396C61Q38935027-B5DD8CDE-3165-4E2D-B561-63D843A9EB0FQ40357390-405FDBE6-D5FD-4942-BC98-1392EE45A93AQ42353164-440F3414-BC68-4CBE-97C9-4C33072C664FQ45949842-987C775B-B3EE-4757-B77C-4FE0D45401FB
P2860
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
@ast
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
@en
type
label
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
@ast
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
@en
prefLabel
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
@ast
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
@en
P2093
P356
P1476
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system
@en
P2093
S Petersen
P304
P356
10.3892/IJO.18.3.599
P577
2001-03-01T00:00:00Z